Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias
- 2 January 1990
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (2), 58-64
- https://doi.org/10.1016/0002-9149(90)90204-e
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: Comparison with other antiarrhythmic agentsThe American Journal of Cardiology, 1990
- Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexesThe American Journal of Cardiology, 1990
- Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugsThe American Journal of Cardiology, 1990
- Clinical experience with sotalol in patients with drug-refractory ventricular ArrhythmiasJournal of the American College of Cardiology, 1989
- Usefulness of sotalol for drug-refractory malignant ventricular arrhythmiasJournal of the American College of Cardiology, 1988
- Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunctionThe American Journal of Cardiology, 1988
- Sotalol for refractory sustained ventricular tachycardia and nonfatal cardiac arrestThe American Journal of Cardiology, 1988
- Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.Circulation, 1985
- Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.Circulation, 1984
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970